Market Leadership Prollenium US is the only manufacturer of Hyaluronic Acid dermal fillers in North America, offering a unique position that can be leveraged to attract clients seeking locally produced, innovative injectables with regulatory approvals from FDA, Health Canada, and CE.

Growing Product Portfolio The recent launch of VAMP, a new dermal product with a combination of PDRN, amino acids, vitamins, and hyaluronic acid, demonstrates active product innovation and opens opportunities to cross-sell and upsell to clinics seeking diverse aesthetic solutions.

Expanding Global Reach With over four million syringes sold across 80+ countries, Prollenium’s extensive international presence suggests potential for collaboration with new distributors and clinics in emerging markets looking for proven, regulated aesthetic products.

Innovation and Regulatory Edge Prollenium’s commitment to innovation and maintaining multiple regulatory approvals indicates a strong foundation for entering new markets or expanding product offerings to clinics prioritizing safe and approved aesthetic treatments.

Industry Recognition Participation in industry events like the Revanesse Redefine Conference positions Prollenium as a thought leader in the aesthetic space, providing a platform to network with potential clients and showcase cutting-edge product developments to boost sales opportunities.